Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep 20;6(9):e84.
doi: 10.1038/emi.2017.71.

Novel and classical human astroviruses in stool and cerebrospinal fluid: comprehensive screening in a tertiary care hospital, Switzerland

Affiliations

Novel and classical human astroviruses in stool and cerebrospinal fluid: comprehensive screening in a tertiary care hospital, Switzerland

Samuel Cordey et al. Emerg Microbes Infect. .

Abstract

Classical human astroviruses (HAstV) are the third most common cause of non-bacterial acute gastroenteritis. Due to the lack of routine molecular assays, novel HAstV are underdiagnosed and the magnitude of their contribution to clinical disease remains unknown. To better understand their prevalence and the susceptible patient profile, we conducted a comprehensive screening of novel and classical HAstV in stool and cerebrospinal fluid (CSF) samples collected for clinical care in a tertiary care hospital using a specially designed rRT-PCR panel for the detection of novel (MLB1-3 and VA1-4) and classical HAstV. Of the 654 stool samples, 20 were positive for HAstV, and the novel (n=10; 3 MLB1, 4 MLB2; 3 VA2) and classical (n=10) serotypes were equally prevalent. None of the 105 CSF samples were positive. Investigating the patient profile, we found a higher prevalence (P=0.0002) of both novel and classical HAstV in pediatric stool samples (3.4% and 3%, respectively) compared with adult stool samples (0.5% and 0.7%, respectively). Furthermore, all novel and classical HAstV-positive pediatric subjects were ≤four years old, demonstrating similar susceptible populations. Forty-five percent of positive patients were immunocompromised (novel: 40%, classical: 50%). A comparison of novel and classical HAstV-positive cases showed a lower viral load for novel HAstV (P=0.0007) with significantly more upper respiratory symptoms (70% of subjects; P=0.02); this observation may suggest a unique pathogenic pathway. This study confirms the clinical and epidemiological relevance of novel HAstV and identifies a target population in which routine screening may yield clinically valuable information.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study flowchart using eight rRT-PCRs to detect human astroviruses in stool and cerebrospinal (CSF) samples sent for viral screening in the laboratory of virology, University Hospitals of Geneva, 2015–2016.
Figure 2
Figure 2
Positive human astroviruses in stool samples. Top: Pie chart showing the prevalence and composition of classical and novel astroviruses among HAstV-positive patients. Bottom: histogram of the temporal distribution of cases. human astrovirus, HAstV.
Figure 3
Figure 3
Classical and novel human astrovirus viral load in stool samples. The horizontal lines denote median log values. ***P<0.001. human astrovirus, HAstV.

Similar articles

Cited by

References

    1. Finkbeiner SR, Holtz LR, Jiang Y et al. Human stool contains a previously unrecognized diversity of novel astroviruses. Virol J 2009; 6: 161. - PMC - PubMed
    1. Johnson C, Hargest V, Cortez V et al. Astrovirus pathogenesis. Viruses 2017; 9: 22. - PMC - PubMed
    1. Guix S, Caballero S, Villena C et al. Molecular epidemiology of astrovirus infection in Barcelona, Spain. J Clin Microbiol 2002; 40: 133–139. - PMC - PubMed
    1. Moser LA, Schultz-Cherry S. Pathogenesis of astrovirus infection. Viral Immunol 2005; 18: 4–10. - PubMed
    1. Borrows CL, Turner PC. Seasonal screening for viral gastroenteritis in young children and elderly hospitalized patients: is it worthwhile? J Hosp Infect 2014; 87: 98–102. - PubMed

MeSH terms